FDA inspection
Mark A. Lopatin, MD: FDA inspection ending Feb 22, 2000
FDA inspection 18543 · Voluntary Action Indicated (VAI) · Willow Grove, PA
Key facts
| Inspection ID | 18543 |
|---|---|
| Firm | Mark A. Lopatin, MD |
| FEI number | 3002936273 |
| Address | 2360 Maryland Rd |
| City | Willow Grove |
| State | PA |
| ZIP | 19090-1709 |
| Fiscal year | 2000 |
| Inspection end date | Feb 22, 2000 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data